サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1697924

神経可塑性強化装置の世界市場：市場規模・シェア・動向、業界分析 (製品種類別・用途別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.18円
神経可塑性強化装置の世界市場：市場規模・シェア・動向、業界分析 (製品種類別・用途別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)
出版日: 2025年03月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の神経可塑性強化装置の市場規模は2034年までに714億米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

神経可塑性とは、新しい神経接続を形成することによってそれ自体を再編成する脳の能力であり、神経科学、認知科学、医学研究において主要な焦点となっています。最近の動向では、技術の進歩により、脳機能の最適化、学習の促進、リハビリテーションの補助、さらには自然の限界を超えて認知能力を高めることを目的とした神経可塑性強化装置が開発されています。これらの装置は、神経可塑性の変化を促すために、電気刺激や磁気刺激、脳波変調、ニューロフィードバック、感覚増強など、さまざまな技術を用います。

経頭蓋磁気刺激（TMS）は広く使われている装置で、磁場を用いて脳に電流を誘導し、神経の再編成を促進します。TMSはうつ病の治療薬として承認されており、パーキンソン病や慢性疼痛など、他の神経疾患の治療にも有効であることが示されています。

これらの装置により、ユーザーは自分の脳活動をリアルタイムでモニターし、調整することができます。脳波（EEG）ベースのニューロフィードバック装置は、脳波パターンを追跡し、視覚的、聴覚的、または触覚的な合図を通してフィードバックを提供し、ユーザーが望ましい状態に向けて脳活動を訓練するのを助ける。ブレイン・コンピューター・インターフェイス（BCI）もまた、神経可塑性の強化において重要な役割を果たしています。BCIは、麻痺や神経変性疾患に罹患している人々にとって特に大きな変革をもたらしており、機能的自立を取り戻すことを可能にしています。

神経可塑性強化装置市場：分析概要

製品種類別では、経頭蓋磁気刺激（TMS）機器セグメントが、神経疾患や精神疾患の治療における有効性が実証されていることから、2024年に神経可塑性強化装置市場で最大のシェアを占めました。

エンドユーザー別では、認知機能強化や神経学的リハビリテーションのために個人が便利で費用対効果の高いソリューションを求めているため、在宅医療セグメントが今後数年間で支配的なシェアを占めると予測されています。

北米は、その強力な医療インフラ、高度な神経技術の高い採用率、神経疾患の有病率の増加により、2024年の世界の神経可塑性強化装置市場の収益シェアを独占しました。

アジア太平洋の市場は、急速な都市化、医療支出の増加、脳に対する意識の高まりにより、今後数年間で成長すると予想されます。

世界の主要企業の一例として、BioSerenity社、Blackrock Neurotech社、BrainCo社、BrainsWay社、Ceribell社、EMOTIV社、Flow Neuroscience社、Neurable社、Neuralink社、NeuroPace社、Paradromics社、Synchron社などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 世界の神経可塑性強化装置市場の洞察

  • 市場スナップショット
  • 神経可塑性強化装置の市場力学
    • 促進要因と機会
      • 世界の高齢化人口の増加
      • 若年層におけるうつ病の有病率増加
    • 抑制要因と課題
      • 高額な費用と認知度の低さ
  • PESTLE分析
  • 神経可塑性強化装置市場の動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の神経可塑性強化装置市場：製品種類別

  • 主な調査結果
  • イントロダクション
  • 経頭蓋磁気刺激（TMS）装置
  • 経頭蓋直流電流刺激（tDCS）装置
  • 脳波（EEG）ベース装置
  • その他

第6章 世界の神経可塑性強化装置市場：用途別

  • 主な調査結果
  • イントロダクション
  • 認知能力の向上
  • 脳卒中・外傷性脳損傷からの回復
  • メンタルヘルス・神経疾患
  • 学習・記憶改善
  • その他

第7章 世界の神経可塑性強化装置市場：エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院・診療所
  • 研究機関・学術センター
  • 在宅医療
  • その他

第8章 世界の神経可塑性強化装置市場：地域別

  • 主な調査結果
  • イントロダクション
    • 神経可塑性強化装置市場の分析：地域別（2020～2034年）
  • 北米
    • 北米：製品種類別（2020～2034年）
    • 北米：用途別（2020～2034年）
    • 北米：エンドユーザー別（2020～2034年）
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品種類別（2020～2034年）
    • 欧州：用途別（2020～2034年）
    • 欧州：エンドユーザー別（2020～2034年）
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋：製品種類別（2020～2034年）
    • アジア太平洋：用途別（2020～2034年）
    • アジア太平洋：エンドユーザー別（2020～2034年）
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：製品種類別（2020～2034年）
    • 中東・アフリカ：用途別（2020～2034年）
    • 中東・アフリカ：エンドユーザー別（2020～2034年）
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品種類別、2020-2034年
    • ラテンアメリカ：用途別（2020～2034年）
    • ラテンアメリカ：エンドユーザー別（2020～2034年）
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 事業拡大・企業買収の分析
    • 事業拡大
    • 企業買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo Inc.
  • BrainsWay
  • Ceribell, Inc.
  • EMOTIV
  • Flow Neuroscience
  • Neurable
  • Neuralink
  • NeuroPace, Inc.
  • Paradromics
  • Synchron
図表

List of Tables:

  • Table 1 Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 2 Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 4 North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 5 North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 7 U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 10 Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 16 UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 17 UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 19 France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 20 France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 22 Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 28 Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 34 Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 43 China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 44 China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 46 India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 47 India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 52 Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 58 South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 73 UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 76 Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 79 South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 88 Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 94 Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neuroplasticity Enhancement Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Neuroplasticity Enhancement Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End User
  • Figure 11. Global Neuroplasticity Enhancement Devices Market, by End User, 2024 & 2034 (USD Billion)
目次
Product Code: PM5416

The global neuroplasticity enhancement devices market size is expected to reach USD 71.40 billion by 2034, according to a new study by Polaris Market Research. The report "Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type [Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Electroencephalogram (EEG)-Based Devices, and Others], Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, has been a major focus in neuroscience, cognitive science, and medical research. In recent years, advancements in technology have led to the development of neuroplasticity enhancement devices, which aim to optimize brain function, accelerate learning, aid in rehabilitation, and even enhance cognitive abilities beyond natural limits. These devices use a variety of techniques, including electrical and magnetic stimulation, brainwave modulation, neurofeedback, and sensory augmentation, to encourage neuroplastic changes.

Transcranial magnetic stimulation (TMS) is a widely used device that employs magnetic fields to induce electric currents in the brain, facilitating neural reorganization. TMS has been approved for treating depression and has shown effectiveness in treating other neurological disorders, such as Parkinson's disease and chronic pain conditions.

These device allow users to monitor and regulate their brain activity in real time, providing a form of self-directed neuroplasticity training. Electroencephalography (EEG)-based neurofeedback devices track brainwave patterns and provide feedback through visual, auditory, or haptic cues, helping users train their brain activity toward desired states. Brain-computer interfaces (BCIs) are also playing a crucial role in neuroplasticity enhancement. BCIs have been particularly transformative for individuals affected by paralysis or neurodegenerative conditions, enabling them to regain functional independence.

Neuroplasticity Enhancement Devices Market Report Highlights

In terms of product type, the transcranial magnetic stimulation (TMS) devices segment held the largest neuroplasticity enhancement devices market share in 2024 due to their proven effectiveness in treating neurological and psychiatric disorders.

Based on end user, the home care settings segment is projected to hold a dominant share in the coming years as individuals seek convenient, cost-effective solutions for cognitive enhancement and neurological rehabilitation.

North America dominated the global neuroplasticity enhancement devices market revenue share in 2024 due to its strong healthcare infrastructure, high adoption of advanced neurotechnology, and increasing prevalence of neurological disorders.

The market in Asia Pacific is expected to grow in the coming years, owing to rapid urbanization, increasing healthcare expenditures, and growing awareness of the brain.

A few of the global key market players are BioSerenity; Blackrock Neurotech; BrainCo Inc.; BrainsWay; Ceribell, Inc.; EMOTIV; Flow Neuroscience; Neurable; Neuralink; NeuroPace, Inc.; Paradromics; and Synchron.

Polaris Market Research has segmented the neuroplasticity enhancement devices market report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcranial Direct Current Stimulation (tDCS) Devices
  • Electroencephalogram (EEG)-Based Devices
  • Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

  • Cognitive Enhancement
  • Stroke & Traumatic Brain Injury Recovery
  • Mental Health & Neurological Disorders
  • Learning & Memory Improvement
  • Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals & Clinics
  • Research Institutions & Academic Centers
  • Home Care Settings
  • Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Neuroplasticity Enhancement Devices Market Insights

  • 4.1. Neuroplasticity Enhancement Devices Market - Market Snapshot
  • 4.2. Neuroplasticity Enhancement Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Geriatric Population Globally
      • 4.2.1.2. Growing Prevalence of Depression Among Young Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neuroplasticity Enhancement Devices Market Trends
  • 4.6. Value Chain Analysis

5. Global Neuroplasticity Enhancement Devices Market, by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  • 5.3. Transcranial Magnetic Stimulation (TMS) Devices
    • 5.3.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Magnetic Stimulation (TMS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.4. Transcranial Direct Current Stimulation (tDCS) Devices
    • 5.4.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Direct Current Stimulation (tDCS) Devices, by Region, 2020-2034 (USD Billion)
  • 5.5. Electroencephalogram (EEG)-Based Devices
    • 5.5.1. Global Neuroplasticity Enhancement Devices Market, by Electroencephalogram (EEG)-Based Devices, by Region, 2020-2034 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Neuroplasticity Enhancement Devices Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cognitive Enhancement
    • 6.3.1. Global Neuroplasticity Enhancement Devices Market, by Cognitive Enhancement, by Region, 2020-2034 (USD Billion)
  • 6.4. Stroke & Traumatic Brain Injury Recovery
    • 6.4.1. Global Neuroplasticity Enhancement Devices Market, by Stroke & Traumatic Brain Injury Recovery, by Region, 2020-2034 (USD Billion)
  • 6.5. Mental Health & Neurological Disorders
    • 6.5.1. Global Neuroplasticity Enhancement Devices Market, by Mental Health & Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 6.6. Learning & Memory Improvement
    • 6.6.1. Global Neuroplasticity Enhancement Devices Market, by Learning & Memory Improvement, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Neuroplasticity Enhancement Devices Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Neuroplasticity Enhancement Devices Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
  • 7.4. Research Institutions & Academic Centers
    • 7.4.1. Global Neuroplasticity Enhancement Devices Market, by Research Institutions & Academic Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Home Care Settings
    • 7.5.1. Global Neuroplasticity Enhancement Devices Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neuroplasticity Enhancement Devices Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Neuroplasticity Enhancement Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Neuroplasticity Enhancement Devices Market - North America
    • 8.3.1. North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Neuroplasticity Enhancement Devices Market - U.S.
      • 8.3.4.1. U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Neuroplasticity Enhancement Devices Market - Canada
      • 8.3.5.1. Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Neuroplasticity Enhancement Devices Market - Europe
    • 8.4.1. Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Neuroplasticity Enhancement Devices Market - UK
      • 8.4.4.1. UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Neuroplasticity Enhancement Devices Market - France
      • 8.4.5.1. France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Neuroplasticity Enhancement Devices Market - Germany
      • 8.4.6.1. Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Neuroplasticity Enhancement Devices Market - Italy
      • 8.4.7.1. Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Neuroplasticity Enhancement Devices Market - Spain
      • 8.4.8.1. Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Neuroplasticity Enhancement Devices Market - Netherlands
      • 8.4.9.1. Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Neuroplasticity Enhancement Devices Market - Russia
      • 8.4.10.1. Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Neuroplasticity Enhancement Devices Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Neuroplasticity Enhancement Devices Market - Asia Pacific
    • 8.5.1. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Neuroplasticity Enhancement Devices Market - China
      • 8.5.4.1. China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Neuroplasticity Enhancement Devices Market - India
      • 8.5.5.1. India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Neuroplasticity Enhancement Devices Market - Malaysia
      • 8.5.6.1. Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Neuroplasticity Enhancement Devices Market - Japan
      • 8.5.7.1. Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Neuroplasticity Enhancement Devices Market - Indonesia
      • 8.5.8.1. Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Neuroplasticity Enhancement Devices Market - South Korea
      • 8.5.9.1. South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Neuroplasticity Enhancement Devices Market - Australia
      • 8.5.10.1. Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Neuroplasticity Enhancement Devices Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Neuroplasticity Enhancement Devices Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Neuroplasticity Enhancement Devices Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Neuroplasticity Enhancement Devices Market - UAE
      • 8.6.5.1. UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Neuroplasticity Enhancement Devices Market - Israel
      • 8.6.6.1. Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Neuroplasticity Enhancement Devices Market - South Africa
      • 8.6.7.1. South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Neuroplasticity Enhancement Devices Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Neuroplasticity Enhancement Devices Market - Latin America
    • 8.7.1. Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Neuroplasticity Enhancement Devices Market - Mexico
      • 8.7.4.1. Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Neuroplasticity Enhancement Devices Market - Brazil
      • 8.7.5.1. Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Neuroplasticity Enhancement Devices Market - Argentina
      • 8.7.6.1. Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Neuroplasticity Enhancement Devices Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BioSerenity
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Blackrock Neurotech
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BrainCo Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BrainsWay
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Ceribell, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. EMOTIV
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Flow Neuroscience
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Neurable
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Neuralink
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeuroPace, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Paradromics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Synchron
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development